Hot Topics


View all hot topics

1/4

Page 1 Page 2 Page 3 Page 4
  • Mobile Phone

    Tripping the light fantastic, Visible-light communication

    1 February 2012

    A recent article in The Economist highlighted one of the new gadgets unveiled at the recent Consumer Electronics Show in Las Vegas - a pair of smartphones able to exchange data using light. These phones, as yet only prototypes from Casio, a Japanese firm, transmit digital signals by varying the intensity of the light given off from their screens. Sagentia's Euan Morrison, Head of Advanced Optics & Lighting, comments on this technology and the advancements in this area.

    » Find out more

  • Demonstration of Actuation-at-a-Distance Effect for Labs on a Chip

    25 January 2012

    A recent article in MIT Technology Review looked at how microelectromechanical devices could soon be remotely controlled using light thanks to a proof-of-concept experiment demonstrating ‘photoelectrowetting’. Whilst this is interesting there is still a way to go to making this ultimately useful.

    » Find out more
  • Energy harvesting

    Why we need smart meters

    18 January 2012

    Investment in infrastructure is always expensive. The installation of smart meters in every home in Britain is expected to cost £350 per home, for a total cost to the UK economy of £11bn. The government estimates the value to the country at £18bn over a 20 year period, from a combination of energy savings, avoided infrastructure, and reduced running costs. But the high cost of the rollout is being questioned.

    » Find out more
  • DNA strands

    Stakes raised in clinical adoption of genome sequencing

    11 January 2012

    The stakes were raised this week in the field of genome sequencing following the announcement by Ion Torrent technologies that they have begun taking orders for a platform capable of sequencing the human genome in one day for the price of $1000.

    » Find out more
  • Reducing costs and IP strategy and analysis

    How is the economic environment affecting your IP strategy?

    5 January 2012

    At Sagentia we think there are some interesting ways that you might evolve the generation, management and use of formal intellectual property in your R&D programmes but we are aware that this must be done in light of wider industry and economic issues.

    » Find out more
  • Solar panels

    Continuing improvements in solar cell technology

    5 January 2012

    Sagentia has commented on an article in the MIT Tech Review about a new low-energy method of making solar cells that could cut the manufacturing costs nearly in half, making them far more efficient and cheaper than conventional cells.

    » Find out more
  • Seedlings

    Innovating in a downturn

    9 September 2011

    Numerous research reports over the past decade have shown that companies that innovate during a downturn do disproportionately well, and those that do not spend on innovation, do not; in fact 30% of companies on the top 10 list for their sector dropped off that list during the 2001 recession. So, why exactly is this and is there a strategy that the winners adopt?

    » Find out more
  • Engineers motor bike

    Medical devices for world’s poorest on show

    19 September 2011

    Voltage regulators, infrared sensor technology and ultrasound scanners are just some of the donated equipment lying redundant in the world's poorest countries.  This BBC article describes how, according to the World Health Organization, some three-quarters of medical devices given by rich countries to developing nations remain unused.

    » Find out more

Events

Frost & Sullivan Medical Devices MindXchange

11-13 March 2012

Sagentia will once again be facilitating an interactive workshop at this annual event.

» Find out more

PCD (Perfumes, Cosmetics & Design) congress

8 February 2012

Visit our booth at the PCD (Perfumes, Cosmetics & Design) congress in Paris to learn how we can help you become more innovative.

» Find out more

Press Releases

PathoGenetix and Sagentia to develop commercial scale rapid microbial detection system

13 December 2011

Sagentia, an international technology and product development company, announced today that it has been selected by PathoGenetix to develop a commercial scale system for rapid microbial detection and strain typing based on PathoGenetix’s Genome Sequence Scanning Technology (GSS). The system is being designed to capitalize on the broad range of potential GSS applications that span microbial genomics research, food and product safety, and clinical infectious disease testing.

Sagentia selected by PathoGenetix to develop commercial-scale, rapid microbial detection system (PDF)

» Find out more

The Gen Autumn 2011

14 november 2011

In this edition of The Gen, our first feature article explores the new trend towards device innovation in the personal care, health and beauty industry. The article discusses why this is important now and the steps to success. The second feature looks at product development for start ups and the things we need to consider as established companies increasingly rely on start-ups as their source of innovation. Elsewhere we take a specific look at the future of smart cities and how this could be enabled by energy harvesting technology.

The Gen Autumn 2011 (PDF)

» Find out more

Press Coverage

Interview with PathoGenetix and Sagentia about Rapid Microbial Detection Technology: Medgadget

31 January 2012

Medgadget interviewed PathoGenetix and Sagentia that are developing a state-of-the-art Genome Sequence Scanning (GSS) technology, which promises to bring rapid microbial detection to the fields of microbial genomics research, food and product safety, and clinical infectious disease testing.

» Find out more

Personalised medicine and companion diagnostic device development

3 January 2012

Personalised medicine is a new field that has often been defined as ‘the right treatment for the right person at the right time’. The essence of the concept is accounting for the differences in an individual patient’s genetic profile in a way that anticipates and overcomes potential complications and adverse drug reactions. Companion diagnostics is a key attribute of personalised medicine and is the development of diagnostic tests whereby molecular assays that measure levels of proteins, genes or specific mutations are used to provide information for a therapy specific to an individual’s condition. 

This article in the International Pharmaceutical Industry Journal by Sagentia's Nick Rollings discusses this topic in some detail.

Personalised medicine and companion diagnostic device development (PDF)

» Find out more
Search
 
 

RSS Feeds

Keep track of site upates using our RSS feeds, click a link below to view the feed.

News
Resource library

Email newsletters

Keep up to date - sign up for our e-newsletters

Press enquiries

For further information and media enquiries please email
pressoffice@sagentia.com
Certified